Proactive Investors - Run By Investors For Investors

Amryt Pharma signs 'major' licensing deal for gene therapy asset

Amryt Pharma PLC's (LON:AMYT) Joe Wiley catches up with Proactive to discuss the company's 'major' new licensing deal with University College Dublin for a gene therapy asset.

He says the company is seeing encouraging early data and is planning to conduct pre-clinical studies in the coming months.

 
View full AMYT profile View Profile

Amryt Pharma PLC Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use